SCHEMBL25149355

SCHEMBL25149355

COC(=O)c1ccc(-c2ccccc2OCC2CCCCC2)nc1OC

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CD274 Q9NZQ7 4/20 0.52
PDCD1 Q15116 2/20 0.52
ALDH1A1 P00352 1/20 0.45
TSHR P16473 1/20 0.45
CNR1 P21554 2/20 0.44
RIPK1 Q13546 6/20 0.43
PTGER1 P34995 1/20 0.43
PARP15 Q460N3 1/20 0.43
PARP10 Q53GL7 1/20 0.43
FAAH O00519 1/20 0.42
CNR2 P34972 1/20 0.42
HPGD P15428 1/20 0.41
GUCY1B2 O75343 1/20 0.40
GUCY1A2 P33402 1/20 0.40
GUCY1A1 Q02108 1/20 0.40
GUCY1B1 Q02153 1/20 0.40
PDCD1LG2 Q9BQ51 2/20 0.39
VDR P11473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30365021 1.00 CD274 (0.52) CD274PDCD1ALDH1A1TSHRCNR1
SCHEMBL30364797 1.00 CD274 (0.52) CD274PDCD1ALDH1A1TSHRCNR1
SCHEMBL30364692 0.91 CD274 (0.51) CD274PDCD1CNR1RIPK1CNR2
SCHEMBL25149474 0.91 CD274 (0.51) CD274PDCD1CNR1RIPK1CNR2
SCHEMBL30364967 0.91 PTGER1 (0.44) CD274PDCD1CNR1RIPK1PTGER1
SCHEMBL25149242 0.91 PTGER1 (0.44) CD274PDCD1CNR1RIPK1PTGER1
SCHEMBL25148658 0.82 CD274 (0.43) CD274PDCD1RIPK1PTGER1PDCD1LG2
SCHEMBL30365211 0.82 CD274 (0.43) CD274PDCD1RIPK1PTGER1PDCD1LG2
SCHEMBL25149505 0.82 IRAK4 (0.46) CD274PDCD1PARP15PARP10PDCD1LG2
SCHEMBL25149261 0.81 MEN1 (0.39) CD274PDCD1CNR1RIPK1PTGER1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023062575-A1 CYCLIC VINYL SULFONE COMPOUNDS AS WRN INHIBITORS IDEAYA BIOSCIENCES, INC. (US) 2023-04-20 WO disclosed